Category Archives: AZBio News
Nectero Medical Announces Completion of $96M Series D Financing
The proceeds will support the execution of the Phase II/III trial and potential NDA submission for the Nectero EAST System, a Breakthrough Therapy for small to medium-sized AAA.Continue reading
Accelerate Diagnostics Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
Enabling rapid, automated microbial identification directly from positive blood culture samplesContinue reading
Non-Competition Agreements and the FTC
With the recent FTC Ruling Banning Non-Compete Agreements, more attention is now now focused on this long standing business practice. This educational video update on Non-Compete Agreements was hosted by AZBio and presented by Helen Holden of Spencer Fane. Continue reading
Bhattacharya named inaugural executive director of CAMI
The Center for Advanced Molecular and Immunological Therapies will be led by Deepta Bhattacharya, PhD, a renowned immunologist at the College of Medicine – Tucson.Continue reading
Rima Alameddine Named President of BD Peripheral Intervention
FRANKLIN LAKES, N.J. (May 13, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rima Alameddine has been named worldwide president of the BD Peripheral Intervention business unit, effective today.
New BIOSECURE bill “reinforces the national security imperative of the biotechnology industry”
House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement:
“The BIOSECURE bill released in the House today reinforces the national security imperative of the biotechnology industry as a critical strategic asset of the United States of America. It highlights a key vulnerability in our global supply chain and importantly provides a reasonable timeframe for companies to decouple their reliance on China-based biomanufacturing. It ensures during this transition that important biomedical research will not be slowed and that patients will have unimpeded access to life saving medicines.Continue reading
ACA Launches New Tools to Support Arizona Small Business
New loan guarantee and technical assistance programs available for small businesses
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
WASHINGTON, May 8, 2024 – In response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA) have developed a plan to update, streamline, and clarify their regulations and oversight mechanisms for products of biotechnology.Continue reading
ASU researchers develop AI-based tool paving the way for personalized cancer treatments
New freely available tool uncovers new insights into how our body distinguishes between our own cells and potential invaders with unprecedented speedContinue reading